Next Article in Journal
Exercise-Induced Oxidative Stress Responses in the Pediatric Population
Next Article in Special Issue
Red Fruits: Extraction of Antioxidants, Phenolic Content, and Radical Scavenging Determination: A Review
Previous Article in Journal
Acknowledgement to Reviewers of Antioxidants in 2016
Previous Article in Special Issue
Protandim Protects Oligodendrocytes against an Oxidative Insult
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Use of Saliva Biomarkers to Monitor Efficacy of Vitamin C in Exercise-Induced Oxidative Stress

Nutrition Program, Agriculture, Nutrition and Veterinary Science Department, University of Nevada, Reno, NV 89557, USA
*
Author to whom correspondence should be addressed.
Antioxidants 2017, 6(1), 5; https://doi.org/10.3390/antiox6010005
Submission received: 10 November 2016 / Revised: 19 December 2016 / Accepted: 9 January 2017 / Published: 12 January 2017
(This article belongs to the Special Issue Feature Papers 2016)

Abstract

:
Saliva is easily obtainable for medical research and requires little effort or training for collection. Because saliva contains a variety of biological compounds, including vitamin C, malondialdehyde, amylase, and proteomes, it has been successfully used as a biospecimen for the reflection of health status. A popular topic of discussion in medical research is the potential association between oxidative stress and negative outcomes. Systemic biomarkers that represent oxidative stress can be found in saliva. It is unclear, however, if saliva is an accurate biospecimen as is blood and/or plasma. Exercise can induce oxidative stress, resulting in a trend of antioxidant supplementation to combat its assumed detriments. Vitamin C is a popular antioxidant supplement in the realm of sports and exercise. One potential avenue for evaluating exercise induced oxidative stress is through assessment of biomarkers like vitamin C and malondialdehyde in saliva. At present, limited research has been done in this area. The current state of research involving exercise-induced oxidative stress, salivary biomarkers, and vitamin C supplementation is reviewed in this article.

1. Introduction

Free radicals and their potentially destructive nature were recognized in a laboratory as early as 1900 [1]. A free radical, for the purpose of this review, is defined as a compound that has one or more unpaired electrons in its orbital and is capable of finite existence (Figure 1) and includes superoxide [2,3]. Free radicals have extremely high chemical reactivity, which can in turn cause damage to cells. Reference 1 researchers investigating carbons and hydrocarbons acknowledged that oxygen derivatives were causing reactions within their experiments [1]. “Oxidation” was termed as the environment’s oxygen as it bound with chemical constituents. Since this century-old occurrence, studies have continued to examine oxidation, its properties, and how it can affect a multitude of health-related outcomes. The adverse effects of oxidation and free radicals were hypothesized by the mid-1900s and further examined by Gerschman et al. [4], who compared and identified the dangers of oxidation and radiation. Their findings led to future research more closely examining free radicals and consequences associated with their presence. It should be noted that the generation of free radicals is not always negative. A number of reactions essential to life, such as the generation of phagocytic cells to kill invading pathogens, along with those related to intercellular and intracellular signaling, are important beneficial effects.
Free radical species include reactive oxygen species (ROS), reactive nitrogen species (RNS), and a variety of compounds that can become reactive from surrounding free radicals; such compounds can include carbons, carbonyls, lipids, proteins, sulfur, halogen and nucleotides [5,6,7,8,9,10,11,12,13]. It can be argued that with time, individual organisms are exposed to more and more oxidizing elements resulting in more free radicals. These oxidizing elements are found in everyday life. Theoretically speaking, this would cause an accumulation of free radical damage needing to be repaired in order to avoid the correlated dangers of such instances. Antioxidants can reduce free radicals to less-harmful compounds at the expense of such antioxidants, which in turn become oxidized. One factor recognized as causing increased oxidation is exercise, known as exercise-induced oxidative stress. Davies was one of the first who found that exercise can induce oxidative stress as exhaustive exercise increased free radical production [14].
Biomarkers of oxidative stress have been a major source of debate related to monitoring oxidative stress and the possible resulting damage. Biomarkers of oxidative stress have been measured in plasma, whole blood, urine, respired gases, muscle, and other skeletal tissues. One possible biospecimen that is still requiring investigation is saliva, as it has the potential to be utilized for measuring a variety of biomarkers in relation to antioxidants and oxidative stress. Saliva is an attractive biospecimen for a number of reasons including the ease of its collection and the high-amount the human body is capable of producing for examination. Because indices for oxidative stress increase in exercise, dietary supplements are often used to counter such negative effects as soreness and fatigue. Furthermore, dietary supplements are often used to enhance exercise performance. Vitamin C is an antioxidant that has been used as a dietary supplement to mitigate exercise-induced oxidative stress, the negative results of unchecked free radicals, and the possible alterations in exercise-induced adaptation that might come of the vitamin’s consumption. This review paper will address these areas with the inclusion of the most recent research.

2. Oxidative Stress and Free Radicals

2.1. Basic Concepts

Reduction and oxidation reactions, or redox reactions, involve the process of electron transport between molecular orbitals. When a compound is reduced, it gains an electron in its orbital for stabilization; alternatively, when a compound is oxidized, it loses an electron from its orbital. Oxidization usually leads to an unpaired electron, turning it into a free radical or a compound known as a reactive species. Redox reactions are coupled in systems such as biological organisms; normally, these are balanced and otherwise healthy reactions unless some sort of “stress” should cause an imbalance between reduction and oxidation. The imbalance is usually skewed towards oxidation and is defined as oxidative stress; that is, a buildup of reactive species/free radicals (such as reactive oxygen species or reactive nitrogen species) which are not being reduced at an equal pace by antioxidants and leading to potential damage [15].
It should be recognized that oxygen is one of the more toxic chemicals in oxidative stress when not reduced. Oxygen is, however, a necessity for a wide range of organisms, being the final acceptor in electron transportation during ATP synthesis. Because of oxygen’s molecular structure, it is very capable of free radical formation and contributes highly to reactive oxygen species as a whole. This is interesting, given not only its biological necessity, but also given it is the most abundant chemical in the Earth’s atmosphere at 21% [16,17]. Exposure to high concentrations of oxygen or to anything leading to toxic concentrations of oxygen that cannot be reduced is known to be detrimental to organisms such as plants, animals, and bacteria [18,19,20]. To combat oxygen toxicity and its role in free radicals formation, such organisms require antioxidant defenses from both endogenous and exogenous sources. Humans are especially susceptible to high concentrations of oxygen exposure in the lungs because of their physiological function [21], but other tissues are capable of high concentrations as well. Oxygen at lower concentrations (e.g., hypoxia) can also produce biomarkers of oxidative stress [2]; this suggests oxygen’s balance is an important factor in oxidative stress.
The simplest free radical is atomic hydrogen. Free radicals can be highly reactive to other components and compounds in that they search for electrons to pair with their unpaired electrons. Such electrons often come from nucleotides, lipids, proteins, and/or other molecules throughout the surrounding system that are paramagnetic. This process, in turn, oxidizes these substances, potentially resulting in an array of problems such as mutation and dysfunction. The superoxide radical is one of the more common free radicals; it can either oxidize substances or create other free radicals [2]. Other known free radicals are hydroperoxyl, hydroxyl, peroxyl, alkoxyl, carbonate, carbon dioxide, and O2 [22]. Some compounds are considered non-radicals but have still been associated with oxidative stress, such as hydrogen peroxide, peroxynitrite, peroxynitrous acid, nitrosoperoxycarbonate, hypochlorous acid, hypobromous acid, ozone, and singlet O2. Nitrogen, chlorine, bromine, and sulfur have also been shown to produce their own versions of reactive species [23]. Free radicals can be formed under a variety of different circumstances including cell/tissue injury [24] and exercise.

2.2. Health, Disease, and Disorders Associated with Oxidative Stress

Based on the existing research on free radicals and oxidative stress and their potential association with negative outcomes, it is easy to misinterpret the available information and conclude that these are unhealthy and (at times) detrimental compounds. Possible cell death can occur via oxidative stress and free radical exposure. The list of clinical conditions associated with oxidative stress and free radicals is exhaustive; however, whether they are causative for these conditions or simply byproducts is not yet established. Some examples of research involving health conditions and their associations with free radicals are described below:
Porphyria is a condition in humans where heme’s biosynthesis is abnormal in such a way that leads to skin and tissue damage in severe cases, and often, a buildup of free radicals [25,26]. Atherosclerosis and cardiovascular disease are two of the leading causes of death worldwide [27,28]. Inflammatory and oxidative biomarkers (C-reactive protein and Myeloperoxidase) may accompany these conditions (and therefore are associated) [29]. Diabetes (among the 10 leading causes of death in the USA [30]) has been induced through introduction of oxidizing-toxins in laboratory conditions [31,32]. Furthermore, biomarkers of oxidative stress are shown to be increased with diabetes [33,34]. Reactive species and compounds that can generate reactive species have been shown to generate more rapidly during times of carcinogenesis and are increased in tumors [35,36]; cancer is another condition among the leading causes of death in the USA [30]. Research has established free radical production plays a role in aging. Researchers are working to establish the potential relationship between varying free radical and antioxidant concentrations as they relate to cell life and longevity [37,38,39,40].
Oxidation and free radical production cannot be avoided entirely, as organisms are both exposed to them from exogenous sources and through endogenous production. Air pollution, physical activity, high-altitude/hypoxia, inactivity, food, obesity, and UV-light exposure can cause oxidative damage. Furthermore, the mitochondria and phagocytes within the body can cause the production of free radicals [41]. It has been established that in certain biochemical/cellular situations, free radicals and reactive species are necessary for development and function such as in cell growth/proliferation, cell signaling, gene activation, and gene messaging just to name a few [42,43]. Production of reducing agents such as superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPX) occurs endogenously to maintain a balanced redox system [2,44,45]. Exogenous sources of reducing agents, such as vitamin C and vitamin E, also have roles in this redox balance. These reducing agents are better known as antioxidants.
Antioxidants, for the sake of this review, are compounds capable of reducing oxidized compounds, free radicals, reactive species, and oxidative stress. Briefly mentioned earlier, antioxidants can be produced endogenously (e.g., SOD, catalase, and GPX) as well as sourced exogenously (e.g., vitamin C and vitamin E). The antioxidant used to reduce or alleviate the offending agent or oxidative stress depends on: the offending agent (e.g., free radical or reactive species); how it is generated (e.g., exercise); where it is generated (e.g., water-based tissue or lipid-based tissue, intracellularly or extracellularly); and the target of damage (e.g., plasma lipids or plasma proteins) [2]. Furthermore, antioxidants can defend differently against free radicals and/or reactive species; antioxidants SOD, GPX, and catalase act as enzymes and catalytically remove the offender while vitamin C, vitamin E, and reduced glutathione donate electrons to neutralize the offender. Antioxidants that donate electrons in order to reduce oxidative stress, do so at their own expense in that they become oxidized albeit a less harmful/oxidizing agent. Certain antioxidants are more capable of reducing oxidative stress more readily; endogenous sources, such as GPX, are the more capable compounds regarding this while vitamin C and vitamin E are less-so. Still, vitamin C and its related compounds (e.g., dehydroascorbic acid) are more capable than vitamin E and, at times, some endogenous antioxidants at reducing oxidative stress [2].

2.3. The Relationship between Inflammation and Oxidative Stress

Pathogens, trauma, and infections are common offenders which can cause the body to become inflamed. Inflammation is the mechanism used to restrict any sort of possible spreading, remove the debris from the damage, and repair the damaged area caused by the offender [46]. The first response to an offending agent such as a pathogen is to quickly mobilize defending leukocytes (such as monocytes and neutrophils) by vasodilation via cytokines. Cytokines such as interleukins and tumor necrosis factors will formulate to signal surrounding sensors to begin the necessary mechanisms for repair and restoration [47]; these are common inflammatory biomarkers. The next response is for leukocytes and monocytes to engulf debris that might result from the damage. Neutrophils will also catalyze a reaction known as a respiratory burst in order to neutralize the offender. Superoxide radical, hydrogen peroxide, and hypochlorite are the neutralizing compounds produced by the respiratory burst [48,49]; these are also reactive and non-reactive species of oxidative stress. The final response of inflammation includes cleanup by monocytes (and eventually macrophages) via phagocytosis [50] and then repair. The known signs of inflammation include redness, swelling, and pain. Inflammation and the aforementioned process are normal in acute situations, much like redox reactions.
It is when chronic inflammation and its mechanism arise, so do dangerous problems. The acute inflammatory response differs from the chronic inflammatory response. Cytokines such as interleukins and tumor necrosis factors tend to be overproduced. This can result in systemic inflammation which may be due to an over-abundance of adipose tissue [51]. Metabolic functions will then be disturbed. A variety of diseases have been linked to inflammation from this situation including obesity and diabetes [52], cardiovascular disease [53], and cancer [54].
Both acute inflammation and chronic inflammation will affect, and be affected by, redox components. It has been suggested reactive species (especially 8-oxo-2′-deoxyguanosine (8-oxo-dG), an oxidized derivative of deoxyguanosine and product of DNA oxidation) damaging DNA might be the main culprit in developing metabolic diseases such as cancer [55]. Cancer tumors exhibit an inflammatory response via increases in cytokines such as nuclear factor kappa beta (NF-κB) and tumor necrosis factor alpha (TNFα) [2]; as do situations in cardiovascular disease, diabetes, and hypertension with reactive species being possible initiators [56]. Oxidative stress might even be a secondary process to chronic inflammation [57]. Production of reactive species via inflammatory response (such as superoxide radical, hydrogen peroxide, and hypochlorite) will only exacerbate with chronic inflammation. Myeloperoxidase is another oxidizing agent linked to neurodegenerative and vascular diseases [58,59]. This has begun a trend in researching antioxidants as therapeutic remedies for these serious metabolic diseases [60].
Exercise can stimulate the acute inflammatory response as it is, in fact, damaging tissues on a cellular level [61]. As discussed previously, free radicals and reactive species are possible initiators and products of the inflammatory response. There are a number of interactions between the inflammatory products and reactive species/free radicals; stress hormones such as cortisol are products of the inflammatory response and further rely on redox balance for synthesis. The association between oxidative stress and the inflammatory response in exercise might further explain adaptation to exercise; the body responds to acute inflammation in such a way for the produced antigens to become less harmful [46]. This adaptation might rollover to explaining exercise adaptation, as well.

2.4. Exercise-Induced Oxidative Stress

Exercise can be very beneficial to health [62,63], but may also produce dangerous compounds. Davies was able to measure free radicals in isolated rat muscles via electron paramagnetic resonance following an endurance-exercise bout; exercise intensity increased over time resulted in an increase in free radicals [14]. Originally, researchers hypothesized that exercise could produce free radicals in one of two ways: the electron transport chain or ischemia-reperfusion. These two mechanisms are discussed below. There are now, however, other mechanisms of which are known to produce free radicals via exercise [64]. Included mechanisms are: the xanthine oxidase pathway, which produces the potent hydroxyl radical; the nicotinamide adenine dinucleotide phosphate oxidases pathway, which produces superoxide and hydrogen peroxide; and nitric oxide production, leading to other free radicals such as superoxide and peroxynitrite.
The electron transport chain is a biological mechanism that occurs in the mitochondria. As the name implies, electrons are transported down a gradient of complexes (complexes I through IV) via a series of redox reactions in order to generate the main energy source of adenosine triphosphate (ATP) in mammalian-biological systems. As mentioned earlier, oxygen is used as the final electron acceptor within this mechanism and can be sourced from respiration. Electrons can be “leaked” from this gradient leaving oxygen unpaired and oxidized into the reactive oxygen species, superoxide, or other free radicals [65]. Primary sites of free radical production within the electron transport chain are complexes I and III. During exercise, respiration can intensify as a direct response to the intensity of the activity. The increase in respiration results with an increase in systemic oxygen and electron transport chain activity, especially within the lungs [66,67]. This increase in systemic oxygen is thought to increase approximately 10–20 fold throughout the whole body [68] and 100–200 fold within the isolated, involving muscles [69]. Only about 0.15% of this oxygen, however, can be used to produce a reactive species [70].
Another process that can introduce free radicals is ischemia-reperfusion. When working muscles undergo exercise intensities that meet maximal concentrations of oxygen consumption (VO2max), their oxygen concentrations decrease. During the post-exercise period, these muscles will undergo a rapid increase in oxygen to make up for the lower concentrations present during the VO2max period. At this time, reactive species are produced (Figure 2) [71,72]. If antioxidant defense systems are not capable of reducing such compounds to balance the redox-reaction’s equation, oxidative damage can occur.
While it may first appear that regular exercisers and athletes could be at risk from exercise-induced free radical influx, especially at intense levels and increased duration [73,74,75,76], other research suggests that regular exercisers and athletes adapt to such an influx over time. This adaptation would make them less susceptible to oxidative damage. Individuals who do not exercise regularly are more susceptible to oxidative damage but can become trained and develop a resistance to such damage [77]. The theorized mechanisms explaining why regular exercise improves adaption to oxidative stress include the upregulation of nuclear respiratory factor 1 (NRF-1) and of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α). Both compounds depend on reactive species for activation of their signaling pathways that essentially lead to gene expression, phosphorylation, cell growth, and adaptations in the muscle potentially associated with improvements in exercise and sport performance [78,79,80,81,82]. Most research in exercise-induced oxidative stress has focused on aerobic exercise (e.g., running and bicycling), since oxygen is a major contributor to the synthesis of a reactive species. There is less research, however, regarding anaerobic exercise in the pool of exercise-induced oxidative stress.

2.5. Analyzing Exercise-Induced Oxidative Stress

One challenge in researching exercise-induced oxidative stress, and oxidative stress in general, is deciding which biomarker is most appropriate and if this biomarker is reflecting substantial oxidative damage to the organism. The different biomarkers reflecting lipid peroxidation, protein oxidation, and DNA oxidation and what they truly reflect should be considered. Malondialdehyde, for example, is a biomarker of lipid peroxidation, specifically polyunsaturated fatty acids; it does not necessarily reflect damage as accurately as F2-isoprostanes [2]. Another factor to consider when deciding the biomarker is the time of biospecimen collection; concentrations of certain biomarkers such as malondialdehyde will not peak immediately after the stressor [2]. It can also be difficult to choose which biospecimen (e.g., blood and saliva) to use for biomarker assessment. Blood is the most common for exercise-induced oxidative stress and biomarker extraction. Biomarkers present in blood include protein carbonyls [83,84,85,86]; total antioxidant capacity [87,88]; F2-isoprostanes [89,90]; malondialdehyde [91]; and Thiobarbituric Acid-Reactive Substances (TBARS), of malondialdehyde [92,93]. The presence of such blood biomarkers does not necessarily indicate damage is occurring in the surrounding cells/tissues; malondialdehyde, for instance, can be a product of actual damaged-tissue but also a product of reactive species. Different intensities of exercise and the exercise environment (e.g., high altitude) will also exhibit different concentrations of oxidative stress biomarkers [14,83]. Further research in these areas is warranted.
Saliva as a biospecimen has also been proposed for exercise-induced oxidative stress assessment [94,95]. Research in this area is limited and further research is warranted. Biomarkers used previously to examine oxidative stress and antioxidant status with saliva as a biospecimen include: total antioxidant capacity, uric acid, glutathione, advanced oxidation protein products, nitric oxide, and TBARS [96,97,98,99]; such biomarkers were used both in aerobic and anaerobic exercise conditions. Measuring and assessing oxidative stress in saliva has observed conflicting results using the TBARS assay, despite its popularity. The intensity of the exercise bout is the proposed culprit to this as the more intense exercise-bouts have observed significant increases in salivary TBARS [97] while less intense exercises have not [96]. The lack of sensitivity and specificity with the TBARS assay might also be cause for concern. Uric acid has been cited as a potential antioxidant and has consistently increased in saliva after exercise [96,98,99]; substantial increases might be due to the reduction of lipid peroxides. Free radicals, antioxidants, and all compounds in-between should continue to be studied to fully understand the balance in redox reactions and how it relates to health and exercise. Future research utilizing saliva as a biospecimen should have multiple, reliable biomarkers that are on both ends of the redox spectrum: for example, TBARS or malondialdehyde as oxidative-stress biomarkers and vitamin C and glutathione as antioxidant biomarkers.

3. Use of Salivary Biomarkers

3.1. The Basics of Saliva

Saliva is a fluid found in the oral cavity that has potential in identifying compounds under different diagnostic conditions in health, disease, and oxidative stress. It is comprised mostly of water [100] but also contains a variety of organic and inorganic components such as proteins, enzymes, electrolytes, immunoglobulins, hormones, and micronutrients such as vitamin C [101,102,103,104,105]. These components are essentially blood-based and permeate into the saliva due to different capillaries, acinar cells, and ductal cells [106]. Saliva is secreted into the oral cavity via major and minor glands with stimulation by the medulla [107]. The three major glands are the parotid gland, the sublingual gland, and the submandibular gland; the minor glands are the labial gland, the buccal gland, the lingual gland, and the palatal gland [108,109]. Each individual gland produces different amounts and flow rates of saliva with different compositions of its components at different times of the day. Such amounts and flow rates can also depend on if it is stimulated or unstimulated [103]. Some main functions of salivary components include the breakdown of local bacteria, digestion of carbohydrates and lipids, food lubrication, taste, and oral health [110,111,112].
An average individual can produce between 1 to 1.5 liters of saliva per day [113] making it a very appealing biospecimen in multiple sampling. Furthermore, saliva requires little to no safety-training for extraction and is a noninvasive alternative to blood and serum sample procedures. While it has been seen that some systemic biomarkers in health correlate well between saliva and blood in diagnosis (e.g., HIV [114]; hepatitis [115]; oral cancer [116]; periodontal disease [117,118]; and obesity [119]), saliva is not always the best biospecimen in that it does not always fully represent systemic concentrations such as with amylase, some proteomes, and phosphate [120].

3.2. Biomarkers of Oxidative Stress in Saliva

Technologies have advanced over the last century as well as the accuracy to identify salivary components. Biomarkers such as Malondialdehyde (MDA), 8-oxo-7, 8-oxo-2′-deoxyguanosine (8-oxo-dG), Thiobarbituric Acid-Reacting Substances (TBARS), total antioxidant capacity (TAC), uric acid, and protein carbonyls have been identified in the saliva due to such advancement [114,115,116,117,118,119]. Such biomarkers have been used in research studies focusing on oxidative stress and its association with exercise (discussed previously), health, and disease. Malondialdehyde has been used as a biomarker in recurrent aphthous ulceration (RAU) research with both serum and saliva used as a biospecimen [121,122]. Diabetes mellitus has also been studied with Malondialdehyde as a biomarker of oxidative stress in both serum and saliva despite lacking statistical significance in the control and experimental group concentrations [123]. These confounding results make it difficult to commit to saliva. Future research should focus on using the biomarkers/assays known to be accurate and reliable when assessing exercise-induced oxidative stress. TBARS, for example, is not necessarily the best to reflect oxidative stress or damage despite its ease in conducting. Free MDA and 9-oxo-dG might be considered more relevant as they are such with blood examination [2].

4. Vitamin C

4.1. Vitamin C as a Salivary Biomarker

Vitamin C, also known as ascorbic acid, is an essential micronutrient in that it is a necessity for certain species, including humans, to live. Scurvy (vitamin C deficiency) has been reported as early as 1550 B.C. [124] and led to vitamin C’s discovery in the early 1900s. It is also an antioxidant involved in a variety of hydroxylation reactions. Not long after its discovery was vitamin C found to be located in saliva. In 1935, vitamin C was measured in saliva at a 2.5 μg/mL concentration [125]. Other salivary vitamin C research studies, using salivary vitamin C as an index of vitamin status, helped in our understanding of vitamin C requirements [126,127,128,129,130,131,132]. Mäkilä and Kirveskari [126] are the researchers cited for the recorded range of salivary vitamin C concentration at 0.07–0.09 mg per 100 g of wet tissue; 0.07 mg came from the mixture of whole saliva while 0.09 mg came specifically from the parotid gland’s saliva. Saliva has been difficult to use as a biospecimen due to the failure in showing consistency of correlation with systemic biomarker concentrations. Vitamin C has fallen subject to this inconsistency, as well [128,133]. Research has repeatedly confirmed that other systemic biospecimens (e.g., blood, serum, and plasma) and vitamin C concentrations relate to dietary vitamin C intake [134]. When systemic concentrations of vitamin C fall to a deficient state, however, its salivary component is undetectable; this is likely a function of limited instrumental detection. Another success with saliva has come from the suggested relationship between vitamin C supplementation and salivary vitamin C [126]. Some diseases and disorders have also had significantly lower salivary vitamin C concentrations such as tuberculosis, parodontopathy, periodontitis, cancer, and leprosy [132,135,136,137,138,139]. There has been a lack of consistency in the assays used for determining salivary vitamin C status; the assays that have been used are derived from one of two methods: the dichlorophenolinodophenol method or the dinitophenylhydrazine method [140]. These methods utilize ascorbic acid’s antioxidant capabilities (that is to say that it can be reduced and oxidized easily) for colorimetry readings such as by a spectrophotometer. No study that looked at both exercise and salivary vitamin C was found.

4.2. Systemic Vitamin C

Vitamin C can be actively located in a variety of tissues at a variety of approximate concentrations [140]. Some examples of said tissues include the adrenal gland, plasma, and leukocytes. Plasma is often used as a biospecimen to evaluate systemic vitamin C status due to its response to the body’s systemic concentrations; however, leukocytes are the better tissue in regards to accurate measurements of bodily stores. Symptoms of vitamin C deficiency often occur when total body pools and plasma concentrations are 300 mg or less and 0.2 mg/dL or less, respectively [134,141]. Scurvy symptoms tend to arise when total body vitamin C pools are 300 mg or less [142,143]. Physiological changes related to scurvy can emerge when intakes are as little as 10 mg per day for a month. The Estimated Average Requirement (EAR) is set at 60 mg per day and 75 mg per day for females and males, respectively; this estimated requirement is set and recommended with the prevention of scurvy in mind. Roughly 37% of Americans are not taking in their EAR [144]. The suggested requirements are still debated upon and it is starting to become more theorized that problems might be developing due to such low intakes of vitamin C (and other essential nutrients). These problems include but are not limited to: harmful nitrosamine formation, low density lipoprotein oxidation, fatigue, and irritability [142]. Vitamin C intakes of 1.25 g (supplemented) per day fully saturate the blood plasma but roughly 50% of the vitamin is excreted in the urine [145]; this suggests that the more vitamin C taken in, the more that will be excreted. Around 200 mg is roughly the intake needed for full-body saturation with limited excretion. Doses larger than 500 mg will mostly be excreted [145]. Some of the foods that are higher in vitamin C include (contents of mg/100 g): peppers at 125–200 mg; kale at 120–180 mg; collard greens at 100–150 mg; broccoli at 90–150 mg; spinach at 50–90 mg; strawberries at 40–90 mg; cauliflower at 60–80 mg; and citrus fruits at 50 mg [146]. Scurvy as a vitamin C deficiency has not been completely eradicated despite its simplicity and known manifestations [147,148,149]. Some states that induce oxidative stress will also create lower plasma concentrations of the vitamin such as with smoking and diabetes [150,151,152,153,154,155]. These and similar findings have generated the discussion of other situations which require additional vitamin C from exogenous sources (e.g., food stuff and supplementation).
Vitamin C’s location in the body relates to its activity; as there are a variety of processes that require the vitamin to act as a cofactor, a co-substrate, and as an antioxidant in different tissues. It acts as a cofactor in the hydroxylation reactions that synthesize collagen, a protein found in a variety of tissues (skin, cartilage, ligaments, and tendons) necessary for structural and connective purposes. Proline and lysine residues utilize iron for the formation of 3-hydroxyproline, 4-hydroxyproline, and hydroxylysine [156,157,158]. Iron must be in its reduced state which is completed by vitamin C. Another hydroxylation reaction in which iron must be in its reduced state is the synthesis of carnitine, a compound required for fatty acid transportation into the mitochondria for energy utilization. The enzymes necessary for this reaction to occur are trimethyllysine hydroxylase and γ-butyrobetaine hydroxylase [159]; vitamin C is the agent which reduces iron back to its ferrous state for these reactions. The other metal that is often required in its reduced state during physiological processes is copper; vitamin C will reduce cupric ions to cuprous ions during norepinephrine synthesis. Norepinephrine is a catecholamine and neurotransmitter that has functions in an assortment of sympathetic and central nervous system processes. To exploit these processes, its hydroxylation involving vitamin C is required [160]. Vitamin C is also involved in tyrosine metabolism which requires both iron and copper in their reduced states for phenylalanine monooxygenase and 4-hydroxyphenylpyruvate hydroxylase, respectively, to be active as enzymes [161].

4.3. Vitamin C Supplementation for Exericse-Induced Oxidative Stress

Supplements in sports nutrition is an ever growing market in which vitamin C’s role still remains unknown. Research looking into vitamin C intake and exercise performance was conducted as early as the 1930s [162,163]. With vitamin C being an antioxidant and exercise being an inducer of oxidative stress, it is still one of the most popular supplements utilized and relevant for further research [164]. The evidence to suggest that vitamin C supplementation is beneficial, detrimental, or unavailing in exercise is unclear due to confounding results.
Systemic vitamin C will change as it reacts to different levels and types of oxidative stress, including exercise-induced oxidative stress [165,166,167,168]. Systemic vitamin C will quickly increase immediately after an exercise bout [166,167,168]. A negative feedback loop will occur within a couple of days after the exercise and results in a decrease in systemic concentrations [169,170,171]. The decrease in vitamin C might be its distribution and utilization within redox reactions of the affected tissues (e.g., reducing oxidative stress and/or recycling antioxidants) [172]. Daily training, as seen in athletes and avid exercisers, might then cause a continuous decrease in systemic vitamin C. This might generate a need for an increase in exogenous sources since low vitamin C is related to fatigue and decreased exercise performance. Whether the negative feedback loop normalizes or if specific exercise/sport intensities create different systemic vitamin C concentrations should be looked into further.
Vitamin C can be found in a variety of tissues that undergo exercise-induced oxidative stress. Exercise induced-oxidative stress then can potentially be reduced by the antioxidant, suggesting a use for its supplementation. The literature has conflicting views as far as this issue goes. Results to suggest vitamin C supplementation can attenuate oxidative biomarkers that are increased via exercise have been observed [173,174,175,176]. Whether these attenuations are necessary or even desired has yet to be determined since exercise adaptations might be reliant upon free radicals and reactive species at some sort of concentration. Reducing these compounds might then be to the contrary of the overall goal of exercise improvement. Studies have examined vitamin C supplementation alongside a variety of other antioxidants and their effects on oxidative stress and exercise adaptation on a cellular level (NRF-1 and PGC-1α) [177,178,179]. There is limited research examining these cellular pathways and vitamin C supplementation on its own in humans and should be examined further as it has been examined in rats [180]. There is reason to believe, however, that vitamin C will inhibit the NRF-1 and PGC-1α pathways, resulting in adaptation and improvement hindrance [180]. This would, again, negate the point of antioxidant supplementation within exercise and sport.
Exercise performance can be measured in a variety of different indices: VO2max, work capacity, distance for time, overall distance, muscle force, delayed fatigue, and muscle function to name a few. Supplementation of vitamin C, at doses from 500 mg to 1500 mg, has demonstrated improvements in indices of exercise performance; specifically in regards to timed exercise [181,182,183], delayed fatigue [184], and VO2max [185]. There is research, however, that would suggest that vitamin C can compromise such performance indices, even at varying doses of 400 mg and 1000 mg [180,186]. Vitamin C supplementation without improvement or compromise in exercise performance has also been observed [187,188]. The continuance of its supplementation despite inconsistent results, even at similar doses, warrants future research on vitamin C in exercise. Markers of exercise performance have been lower in individuals with suboptimal vitamin C intakes; such individuals have also encountered higher concentrations of oxidative-stress biomarkers [189,190,191,192]. This is the only definitive situation for which supplementation of vitamin C has been suggested [193,194].

5. Future Research

A potential biospecimen that could be easy to obtain for measuring oxidative stress is saliva. It has been utilized to examine oxidative stress within aerobic and anaerobic exercise conditions; however, the only saliva biomarker consistently affected to reflect oxidative stress has been uric acid. Uric acid is an antioxidant that does not necessarily verify oxidative stress or oxidative damage; multiple salivary biomarkers for oxidative stress should be examined at one time. A significant increase in salivary TBARS was not observed but was so in plasma after resistance training, suggesting resistance training can induce oxidative stress [96]. Salivary TBARS might be more useful when higher intensity exercises are involved [97]. A more commonly recognized and accurate biomarker should be used in representing oxidative stress, such as malondialdehyde via HPLC. To fully depict the redox status during exercise while utilizing saliva as a biospecimen, an antioxidant biomarker should be measured alongside an oxidative-stress biomarker. One well-established antioxidant to be found in saliva is vitamin C. There has been little research conducted in order to suggest that systemic vitamin C can be represented by its salivary measurement. The amount of vitamin C taken in through the diet might or might not affect its salivary content but will increase its systemic content [129,195]. Vitamin C is one of the more popular supplements used in sports and exercise for a multitude of reasons, making it a relevant area for research still. Vitamin C supplementation has little to no evidence to suggest any benefit over the recommended estimated average requirement. Salivary vitamin C should be further researched in an exercised setting as it has not been fully examined.
An area of exercise that is lacking in oxidative stress and vitamin C research is resistance training. Resistance training is becoming more popularly performed in a variety of sport and exercise regimens; it does well at developing and indicating muscle strength and force. Oxidative stress has been induced via resistance exercise [96]. A popular combination in research now, and that has been used with resistance training, is supplementing vitamin C alongside other antioxidants to reduce oxidative stress and increase exercise performance [196,197,198]. Vitamin C alone has had limited research exposure in this area and should be warranted to do so. A positive result was observed with a high dose of vitamin C supplementation in eccentric exercise (a form of resistance training) [199]; a substantial reduction in muscle soreness was observed.
Possible areas of more research in resistance training might be looking at the roles of calcium, H2O2, and vitamin C’s role in such involved processes. Calcium is an important mineral in the body with tasks involving bone health and muscle contraction and force. Reactive oxygen species might have an effect on muscle force on a cellular level [200,201]. Vitamin C is involved in calcium absorption, therefore possibly having a secondary influence on the cellular system of muscle force. H2O2 and other reactive species might also inhibit muscular force [202]. Vitamin C is one of the more common antioxidants to reduce H2O2. The research on vitamin C hindering, enhancing, or having no effect on muscular force is limited and needs further investigation. Whether certain doses of vitamin C intake significantly affect sport and exercise performance should also be taken into consideration as some sort of hormesis effect might be at play.
Oxidative stress is a very normal and sensitive homeostatic event which can be damaging overall. Whether oxidative stress is the primary cause of this damage or just a secondary event is left to be researched further in a variety of different settings which includes exercise. In exercise, it is possible that biomarkers which reflect oxidative stress might play a part in important sport and exercise adaptations on a cellular and molecular level. Future researchers should examine whether such biomarkers reflect real damage or are necessary for exercise adaptation. Certain circumstances might include untrained persons wanting to start exercising or competing in sport. An untrained person might experience oxidative stress as a somewhat damaging situation at first; adaptations that occur over time might result in a beneficial outcome on a cellular and physiological level (Figure 3). A perfect balance between oxidative stress induced via exercise and available antioxidants has been proposed [203]. Whether antioxidant supplementation would alleviate oxidative stress in untrained persons, beneficially, should be further examined. Such benefits might include quicker adaptation to the stress or a reduction in the resulting damage. There might be a certain concentration in which oxidative stress mediators are beneficial before they become harmful; a set parameter suggesting normal concentrations might alleviate this concern. A variety of different variables can affect exercise adaptation and general performance over time (e.g., diet, training intensity, training schedule, level of skill, and performance supplementation); these variables should be controlled in future research.

6. Conclusions

Saliva is a potential biospecimen to be used in a variety of research settings including oxidative stress. It has multiple benefits as a biospecimen which include its easy obtainability, its little required training needed for collection, the body’s ability to produce its unlimited quantity, and its possible reflection of some systemic biomarkers that might identify health status. There has been research to suggest that it does not reflect some biomarkers that are more commonly used in identifying health status. The research regarding exercise and oxidative stress with salivary biomarkers is heavily lacking. Resistance training is lacking more so in research regarding oxidative stress, salivary biomarkers, and vitamin C supplementation. The evidence in recommending supplementation of vitamin C is confounding. The only positive results in vitamin C supplementation are with individuals who have low vitamin C intakes. Ironically, 37% of the population isn’t consuming the estimated average vitamin C requirement; this could theoretically cause symptoms such as decreased exercise-performance and fatigue. Such a requirement can be satisfied by consuming the recommended servings of 5 fruits and vegetables every day. There is evidence to suggest that this estimated requirement should be increased to 95 mg and 200 mg per day for females and males, respectively [134,142].

Author Contributions

Levi W. Evans and Stanley T. Omaye wrote the paper. This review paper was written in partial fulfillment of the requirements for the Master of Science degree in Nutrition at the University of Nevada, Reno.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gomberg, M. An instance of trivalent carbon: Triphenylmethyl. J. Am. Chem. Soc. 1900, 22, 757–771. [Google Scholar] [CrossRef]
  2. Halliwel, B.; Getteridge, J.M.C. Free Radicals in Biology and Medicine, 4th ed.; Oxford University Press: Oxford, MS, USA, 2007. [Google Scholar]
  3. Cristiana, F.; Elena, A.; Nina, Z. Superoxide dismutase: Therapeutic targets in SOD related pathology. Health 2014, 6, 975–988. [Google Scholar] [CrossRef]
  4. Gerschman, R.; Gilbert, D.L.; Nye, S.W.; Dwyer, P.; Fenn, W.O. Oxygen poisoning and X-irradiation: A mechanism in common. Science 1954, 119, 623–626. [Google Scholar] [CrossRef] [PubMed]
  5. Semchyshyn, H.M.; Lozinska, L.M. Fructose protects baker’s yeast against peroxide stress: Potential role of catalase and superoxide dismutase. FEMS Yeast Res. 2012, 12, 761–773. [Google Scholar] [CrossRef] [PubMed]
  6. Ferrari, C.K.; Souto, P.C.; França, E.L.; Honorio-França, A.C. Oxidative and nitrosative stress on phagocytes’ function: From effective defense to immunity evasion mechanisms. Arch. Immunol. Ther. Exp. 2011, 59, 441–448. [Google Scholar] [CrossRef] [PubMed]
  7. Bild, W.; Ciobica, A.; Padurariu, M.; Bild, V. The interdependence of the reactive species of oxygen, nitrogen, and carbon. J. Physiol. Biochem. 2013, 69, 147–154. [Google Scholar] [CrossRef] [PubMed]
  8. Radi, R. Peroxynitrite, a stealthy biological oxidant. J. Biol. Chem. 2013, 288, 26464–26472. [Google Scholar] [CrossRef] [PubMed]
  9. Veselá, A.; Wilhelm, J. The role of carbon dioxide in free radical reactions of the organism. Physiol. Res. 2002, 51, 335–339. [Google Scholar] [PubMed]
  10. Lushchak, O.V.; Bayliak, M.M.; Korobova, O.V.; Levine, R.L.; Lushchak, V.I. Buffer modulation of menadione-induced oxidative stress in Saccharomyces cerevisiae. Redox Rep. 2009, 14, 214–220. [Google Scholar] [CrossRef] [PubMed]
  11. Jacob, C. A scent of therapy: Pharmacological implications of natural products containing redox-active sulfur atoms. Nat. Prod. Rep. 2006, 23, 851–863. [Google Scholar] [CrossRef] [PubMed]
  12. Hattersley, J.G. The Negative Health Effects of Chlorine. J. Orthomol. Med. 2000, 15, 89–95. [Google Scholar]
  13. Valko, M.; Morris, H.; Cronin, M.T.D. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12, 1161–1208. [Google Scholar] [CrossRef] [PubMed]
  14. Davies, K.J.; Quintanilha, A.T.; Brooks, G.A.; Packer, L. Free radicals and tissue damage produced by exercise. Biochem. Biophys. Res. Commun. 1982, 107, 1198–1205. [Google Scholar] [CrossRef]
  15. Sies, H. Oxidative Stress: Oxidants and Antioxidants. Exp. Phsiol. 1997, 82, 291–295. [Google Scholar] [CrossRef]
  16. Kasting, J.F. Earth’s early atmosphere. Science 1993, 259, 920–926. [Google Scholar] [CrossRef] [PubMed]
  17. Lane, N. Oxygen, the Molecule That Made the World; Oxford University Press: Oxford, UK, 2002. [Google Scholar]
  18. Halliwell, B. Chloroplast Metabolism; Oxford University Press: Oxford, UK, 1984. [Google Scholar]
  19. Belntine, J.D. Pathology of O2 Toxicity; Academic Press: New York, NY, USA, 1982. [Google Scholar]
  20. Bruyninckx, W.J.; Howard, M.S. Are physiological O2 concentrations mutagenic? Nature 1978, 274, 606–607. [Google Scholar] [CrossRef] [PubMed]
  21. Deneke, S.M.; Fanburg, B.L. Normobaric O2 toxicity of the lung. N. Engl. J. Med. 1980, 303, 76. [Google Scholar] [CrossRef] [PubMed]
  22. Foote, C.S.; Valentine, J.S.; Greenberg, A.; Liebman, J.F. Active O2 in Chemistry; Blackie Academic and Professional: London, UK, 1995. [Google Scholar]
  23. Giles, G.I.; Jacob, C. Reactive sulfur species: An emerging concept in oxidative stress. Biol. Chem. 2002, 383, 375–388. [Google Scholar] [CrossRef] [PubMed]
  24. Symons, M.C.R. Radicals generated by bone cutting and fracture. Free Radic. Biol. Med. 1996, 20, 831–835. [Google Scholar] [CrossRef]
  25. Davies, M.J. Singlet O2- Mediated Damage to Proteins and Its Consequences. Biochem. Biophys. Res. Commun. 2003, 305, 761. [Google Scholar] [CrossRef]
  26. Cox, T.M.; Jack, N.; Lofthouse, S.; Watling, J.; Haines, J.; Warren, M.J. King George III and Porphyria: An Elemental Hypothesis and Investigation. Lancet 2005, 366, 332–335. [Google Scholar] [CrossRef]
  27. Nicholls, S.J.; Hazen, S.L. MPO and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1102–1111. [Google Scholar] [CrossRef] [PubMed]
  28. Roos, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993, 362, 801–809. [Google Scholar] [CrossRef] [PubMed]
  29. Kobayashi, S.; Inoue, N.; Ohashi, Y.; Terashima, M.; Matsui, K.; Mori, T.; Fujita, H.; Awano, K.; Kobayashi, K.; Azumi, H.; et al. Interaction of oxidative stress and inflammatory response in coronary plaque instability: Important role of C-reactive protein. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1398–1404. [Google Scholar] [CrossRef] [PubMed]
  30. Heron, M. Deaths: Leading Causes for 2013. Natl. Vital Stat. Rep. 2016, 65, 5. [Google Scholar]
  31. Hadjivassiliou, V.; Green, M.H.; James, R.F.; Swift, S.M.; Clayton, H.A.; Green, I.C. Insulin secretion, DNA damage, and apoptosis in human and rat islets of Langerhans following exposure to NO, ONOO and cytokines. Nitric Oxide 1998, 2, 429–441. [Google Scholar] [CrossRef]
  32. Grankvist, K.; Marklund, S.L. Opposite effects of two metal-chelators on alloxan-induced diabetes in mice. Life Sci. 1983, 33, 2535–2540. [Google Scholar] [CrossRef]
  33. Davi, G.; Falco, A.; Patrono, C. Determinants of F2-isoprostane biosynthesis and inhibition in man. Chem. Phys. Lipids 2004, 128, 149–163. [Google Scholar] [CrossRef]
  34. Rehman, A.; Nourooz-Zadeh, J.; Möller, W.; Tritschler, H.; Pereira, P.; Halliwell, B. Increased oxidative damage to all DNA bases in patients with type 2 diabetes mellitus. FEBS Lett. 1999, 448, 120–122. [Google Scholar] [CrossRef]
  35. Kumar, B.; Koul, S.; Khandrika, L.; Meacham, R.B.; Koul, H.K. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008, 68, 1777–1785. [Google Scholar] [CrossRef] [PubMed]
  36. Cooke, M.S.; Evans, M.D.; Dizdaroglu, M.; Lunec, J. Oxidative DNA damage: Mechanisms, mutation and disease. FASEB J. 2003, 17, 1195–1214. [Google Scholar] [CrossRef] [PubMed]
  37. Bechman, K.B.; Ames, B.N. Mitochondrial aging: Open questions. Ann. N. Y. Acad. Sci. 1998, 854, 118–127. [Google Scholar] [CrossRef]
  38. Bechman, K.B.; Ames, B.N. The Free Radical Theory of Aging Matures. Physiol. Rev. 1998, 78, 547–581. [Google Scholar]
  39. Bechman, K.B.; Ames, B.N. Endogenous Oxidative Damage of mtDNA. Mutat. Res. 1999, 424, 51–58. [Google Scholar] [CrossRef]
  40. Orr, W.C.; Sohal, R.S. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994, 263, 1128–1130. [Google Scholar] [CrossRef] [PubMed]
  41. Ferreira, L.F.; Reid, M.B. Muscle-derived ROS and thiol regulation in muscle fatigue. J. Appl. Physiol. 2008, 104, 853–860. [Google Scholar] [CrossRef] [PubMed]
  42. Thannickal, V.J.; Fanburg, B.L. Reactive Oxygen Species in Cell Signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279, 1005–1028. [Google Scholar]
  43. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44–84. [Google Scholar] [CrossRef] [PubMed]
  44. Bagchi, K.; Puri, S. Free Radicals and Antioxidants in Health and Disease: A Review. EMHJ 1998, 4, 350–360. [Google Scholar]
  45. Ebadi, M. Antioxidants and Free Radicals in Health and Disease: An Introduction to Reactive Oxygen Species, Oxidative Injury, Neuronal Cell Death and Therapy in Neurodegenerative Diseases; Prominent Press: Scottsdale, AZ, USA, 2001. [Google Scholar]
  46. Saladin, K.S. Anatomy & Physiology: A Unity of Form and Function, 5th ed.; McGraw-Hill: New York, NY, USA, 2010. [Google Scholar]
  47. Nathan, C. Points of control in inflammation. Nature 2002, 420, 846–852. [Google Scholar] [CrossRef] [PubMed]
  48. Brinkmann, V.; Reichard, U.; Goosmann, C.; Fauler, B.; Uhlemann, Y.; Weiss, D.S.; Weinrauch, Y.; Zychlinsky, A. Neutrophil extracellular traps kill bacteria. Science 2004, 303, 1532–1535. [Google Scholar] [CrossRef] [PubMed]
  49. Wang, Q.; Murphy, N.; Black, S.J. Infection-associated decline of Cape buffalo blood catale augments serum trypanocidal activity. Infect. Immun. 1999, 67, 2797–2803. [Google Scholar] [PubMed]
  50. Shapiro, S.D. Immunology: Mobilizing the army. Nature 2003, 421, 223–224. [Google Scholar] [CrossRef] [PubMed]
  51. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 2006, 444, 860–867. [Google Scholar] [CrossRef] [PubMed]
  52. Hotamisligil, G.S.; Erbay, E. Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. 2008, 8, 923–934. [Google Scholar] [CrossRef] [PubMed]
  53. Libby, P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nut. 2006, 83, S456–S460. [Google Scholar]
  54. Trinchieri, G. Cancer and inflammation: An old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 2012, 30, 677–706. [Google Scholar] [CrossRef] [PubMed]
  55. Hagen, T.M.; Huang, S.; Curnutte, J.; Fowler, P.; Martinez, V.; Wehr, C.M.; Ames, B.M.; Chisari, F.V. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 1994, 91, 12808–12812. [Google Scholar] [CrossRef] [PubMed]
  56. Ndisang, J.F.; Vannacci, A.; Rastogi, S. Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications. Oxidative Med. Cell. Longev. 2014, 2014, 506948. [Google Scholar] [CrossRef] [PubMed]
  57. Lugrin, J.; Rosenblatt-Belin, N.; Parapanov, R.; Liaudet, L. The role of oxidative stress during inflammatory processes. Biol. Chem. 2014, 395, 203–230. [Google Scholar] [CrossRef] [PubMed]
  58. Zhang, R.; Brennan, M.L.; Shen, Z.; MacPherson, J.C.; Schmitt, D.; Molenda, C.E.; Hazen, S.L. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J. Biol. Chem. 2002, 277, 46116–46122. [Google Scholar] [CrossRef] [PubMed]
  59. Baldus, S.; Heitzer, T.; Eiserich, J.P.; Lau, D.; Mollnau, H.; Ortak, M.; Petri, S.; Goldmann, B.; Duchstein, H.J.; Berger, J.; et al. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic. Biol. Med. 2004, 37, 902–911. [Google Scholar] [CrossRef] [PubMed]
  60. Bo, L.; Jiang, S.; Kan, H.; Song, W.; Zhao, J. Effect of vitamin E and omega-3 fatty acids on protecting ambient PM2.5-induced inflammatory response and oxidative stress in vascular endothelial cells. PLoS ONE 2016, 11, e0152216. [Google Scholar] [CrossRef] [PubMed]
  61. Niess, A.M.; Dickhuth, H.H.; Northoff, H.; Fehrenbach, E. Free radicals and oxidative stress in exercise—Immunological aspects. Exerc. Immunol. Rev. 1999, 5, 22–56. [Google Scholar] [PubMed]
  62. Christian, J.; Bessesen, D.; Byers, T.; Christian, K.; Goldstein, M.; Bock, B. Clinic-based support to help overweight patients with type 2 diabetes increase physical activity and lose weight. Arch. Intern. Med. 2008, 168, 141–146. [Google Scholar] [CrossRef] [PubMed]
  63. Zhang, C.; Rexrode, K.; Vandam, R.; Li, T.; Hu, F. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: Sixteen years follow-up in US women. Circulation 2008, 117, 1658–1667. [Google Scholar] [CrossRef] [PubMed]
  64. Kerksick, C.M.; Zuhl, M. Mechanisms of oxidative damage and their impact on contracting muscle. In Antioxidants in Sport Nutrition; Lamprecht, M., Ed.; CRC Press/Taylor & Francis: Boca Raton, FL, USA, 2015. [Google Scholar]
  65. Muller, F. The nature and mechanism of superoxide production by the electron transport chain: Its relevance to aging. J. Am. Aging Assoc. 2000, 23, 227–253. [Google Scholar] [CrossRef] [PubMed]
  66. Radak, Z.; Zhao, Z.; Koltai, E.; Ohno, H.; Atalay, H. Oxygen consumption and usage during physical exercise: The balance between oxidative stress and ROS-dependent adaptive signaling. Antioxid. Redox Signal. 2013, 18, 1208–1246. [Google Scholar] [CrossRef] [PubMed]
  67. Freeman, B.A.; Crapo, J.D. Hyperoxia Increases O2 Radical Production in Rat Lungs and Lung Mitochondria. J. Biol. Chem. 1981, 256, 10986–10992. [Google Scholar] [PubMed]
  68. Astrand, P.O.; Rodahl, K. Textbook of Work Physiology; McGraw Hill: New York, NY, USA, 1986. [Google Scholar]
  69. Keul, J.; Doll, E.; Koppler, D. Energy Metabolism of Human Muscle; Karger: Basel, Switzerland, 1972. [Google Scholar]
  70. St-Pierre, J.; Buckingham, J.A.; Roebuck, S.J.; Brand, M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 2002, 277, 44784–44790. [Google Scholar] [CrossRef] [PubMed]
  71. Kellog, E.W., III; Fridovich, I. Superoxide, Hydrogen Peroxide, and Singlet Oxygen in Lipid Peroxidation by a Xanthine Oxidase System. J. Biol. Chem. 1975, 250, 8812–8817. [Google Scholar]
  72. Wolbarsht, M.L.; Fridovich, I. Hyperoxia during reperfusion is a factor in reperfusion injury. Free Radic. Biol. Med. 1989, 6, 61–62. [Google Scholar] [CrossRef]
  73. Gourgoura, S.; Nikolaidis, M.G.; Kostaropoulos, I.A.; Jamurtas, A.Z.; Koukoulis, G.; Kouretas, D. Increased oxidative stress indices in the blood of child swimmers. Eur. J. Appl. Physiol. 2007, 100, 235–239. [Google Scholar] [CrossRef] [PubMed]
  74. Michailidis, Y.; Jamurtas, A.Z.; Nikolaidis, M.G.; Fatouros, I.G.; Koutedakis, Y.; Papassotiriou, I.; Kouretas, D. Sampling time is crucial for measurement of aerobic exercise-induced oxidative stress. Med. Sci. Sports Exerc. 2007, 39, 1107–1113. [Google Scholar] [CrossRef] [PubMed]
  75. Nikolaidis, M.G.; Paschalis, V.; Giakas, G.; Fatouros, I.G.; Kourtedakis, Y.; Kouretas, D.; Jamurtas, A.Z. Decreased blood oxidative stress after repeated muscle-damaging exercise. Med. Sci. Sports Exerc. 2007, 39, 1080–1089. [Google Scholar] [CrossRef] [PubMed]
  76. Nikolaidis, M.G.; Jamurtas, A.Z.; Paschailis, V.; Fatouros, I.G.; Koutedakis, Y.; Kouretas, D. The effect of muscle-damaging exercise on blood and skeletal muscle oxidative stress: Magnitude and time-course considerations. Sports Med. 2008, 38, 579–606. [Google Scholar] [CrossRef] [PubMed]
  77. Radak, Z.; Taylor, A.W.; Ohno, H.; Goto, S. Adaptation to Exercise-Induced Oxidative Stress: From Muscle to Brain. Exerc. Immunol. Rev. 2001, 7, 90–107. [Google Scholar] [PubMed]
  78. Powers, S.K.; Duarte, J.; Kavazis, A.N.; Talbert, E.E. Reactive oxygen species are signaling molecules for skeletal muscle adaption. Exp. Physiol. 2010, 95, 1–9. [Google Scholar] [CrossRef] [PubMed]
  79. Powers, S.K.; Talbert, E.E.; Adhihetty, P.J. Reactive oxygen and nitrogen species as intracellular signals in skeletal muscle. J. Physiol. 2011, 589, 2129–2138. [Google Scholar] [CrossRef] [PubMed]
  80. Kramer, H.F.; Goodyear, L.J. Exercise, MAPK and NF-kappaB signaling in skeletal muscle. J. Appl. Physiol. 2007, 103, 388–395. [Google Scholar] [CrossRef] [PubMed]
  81. Dröge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82, 47–95. [Google Scholar] [CrossRef] [PubMed]
  82. Ji, L.L.; Gomez-Cabrera, M.C.; Vina, J. Exercise and hormesis: Activation of cellular antioxidant signaling pathway. Ann. N. Y. Acad. Sci. 2006, 1067, 425–435. [Google Scholar] [CrossRef] [PubMed]
  83. Ballmann, C.; McGinnis, G.; Peters, B.; Slivka, D.; Cuddy, J.; Hailes, W.; Dumke, C.; Ruby, B.; Quindry, J. Exercise-induced oxidative stress and hypoxic exercise recovery. Eur. J. Appl. Physiol. 2014, 114, 725–733. [Google Scholar] [CrossRef] [PubMed]
  84. Bogdanis, G.C.; Stavrinou, P.; Fatouros, I.G.; Philippou, A.; Chatzinikolaou, A.; Draganidis, D.; Ermidis, G.; Maridaki, M. Short-term high-intensity interval exercise training attenuates oxidative stress responses and improves antioxidant status in healthy humans. Food Chem. Toxicol. 2013, 61, 171–177. [Google Scholar] [CrossRef] [PubMed]
  85. Quindry, J.; Miller, L.; Mcginnis, G.; Kliszczewiscz, B.; Slivka, D.; Dumke, C.; Cuddy, J.; Ruby, B. Environmental temperature and exercise-induced blood oxidative stress. Int. J. Sport Nutr. Exerc. Metab. 2013, 23, 128–136. [Google Scholar] [CrossRef] [PubMed]
  86. Lamprecht, M.; Oettl, K.; Schwaberger, G.; Hofmann, P.; Gerilberger, J.F. Protein modification responds to exercise intensity and antioxidant supplementation. Med. Sci. Sports Exerc. 2009, 41, 155–163. [Google Scholar] [CrossRef] [PubMed]
  87. Leelarungrayub, D.; Khansuwan, R.; Pothongsunun, P.; Klaphajone, J. N-acetylcysteine supplementation controls total antioxidant capacity, creatine kinase, lactate, and tumor necrotic factor-alpha against oxidative stress induced by graded exercise in sedentary men. Oxidative Med. Cell. Longev. 2011. [Google Scholar] [CrossRef] [PubMed]
  88. Wadley, A.J.; Killer, S.C.; Svendsen, I.S.; Gleeson, M. The impact of intensified training with a high or moderate carbohydrate feeding strategy on resting and exercise-induced oxidative stress. Eur. J. Appl. Physiol. 2015, 115, 1757–1767. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  89. Sacheck, J.M.; Milbury, P.E.; Cannon, J.G.; Roubenoff, R.; Blumberg, J.B. Effect of Vitamin E and Eccentric Exercise on Selected Biomarkers of Oxidative Stress in Young and Elderly Men. Free Radic. Biol. Med. 2003, 34, 1575–1588. [Google Scholar] [CrossRef]
  90. McAnulty, L.S.; Miller, L.E.; Hosick, P.A.; Utter, A.C.; Quindry, J.C.; McAnulty, S.R. Effect of resveratrol and quercetin supplementation on redox status and inflammation after exercise. Appl. Physiol. Nutr. Metab. 2013, 38, 760–765. [Google Scholar] [CrossRef] [PubMed]
  91. Bloomer, R.J.; Fisher-Wellman, K.H. Blood oxidative stress biomarkers: Influence of sex, exercise training status and dietary intake. Gend. Med. 2008, 5, 218–228. [Google Scholar] [CrossRef] [PubMed]
  92. Gwozdzinski, K.; Pieniazek, A.; Tabaczar, S.; Jequer, A.; Brzeszczynska, J. Investigation of oxidative stress parameters in different life span erythrocyte fractions in young untrained men after an acute exercise. Exp. Physiol. 2016. [Google Scholar] [CrossRef] [PubMed]
  93. Lee, R.; Margaritis, M.; Channon, K.M.; Antoniades, C. Evaluating oxidative stress in human cardiovascular disease: Methodological aspects and considerations. Curr. Med. Chem. 2012, 19, 2504–2520. [Google Scholar] [CrossRef] [PubMed]
  94. Cavas, L.; Arpinar, P.; Yurdakoc, K. Possible interactions between antioxidant enzymes and free sialic acids in saliva: A preliminary study on elite judoists. Int. J. Sports Med. 2005, 26, 832–835. [Google Scholar] [CrossRef] [PubMed]
  95. Chicharro, J.L.; Lucía, A.; Pérez, M.; Vaquero, A.F.; Ureña, R. Saliva composition and exercise. Sports Med. 1998, 26, 17–27. [Google Scholar] [CrossRef] [PubMed]
  96. Deminice, R.; Sicchieri, T.; Payão, P.O.; Jordão, A.A. Blood and salivary oxidative stress biomarkers following an acute session of resistance exercise in humans. Int. J. Sports Med. 2010, 31, 599–603. [Google Scholar] [CrossRef] [PubMed]
  97. Sant’anna, M.; Casimiro-Lopes, G.; Boaventura, G.; Marques, S.T.; Sorenson, M.M.; Simão, R.; Pinto, V.S. Anaerobic exercise affects the saliva antioxidant/oxidant balance in high-performance pentathlon athletes. Hum. Mov. 2016, 17, 50–55. [Google Scholar] [CrossRef]
  98. González, D.; Marquina, R.; Rondόn, N.; Rodriguez-Malaver, A.J.; Reyes, R. Effects of aerobic exercise on uric acid, total antioxidant activity, oxidative stress, and nitric oxide in human saliva. Res. Sports Med. 2008, 16, 128–137. [Google Scholar] [CrossRef] [PubMed]
  99. Sariri, R.; Damirchi, A.; Nazari, Y. Salivary Antioxidant Variations in Athletes after Intense Exercise. Medicina Sportiva. 2013, 9, 2043–2050. [Google Scholar]
  100. Edgar, W.M. Saliva: Its secretion, composition, and functions. Br. Dent. J. 1992, 172, 305–312. [Google Scholar] [CrossRef]
  101. Van Nieuw Amerongen, A.; Bolscher, J.G.; Veerman, E.C. Salivary proteins: Protective and diagnostic value in cariology? Caries Res. 2004, 38, 247–253. [Google Scholar] [CrossRef] [PubMed]
  102. Zalewska, A.; Zwierz, K.; Zόlkowski, K.; Gindzienski, A. Structure and Biosynthesis of Human Salivary Mucins. Acta. Biochim. Pol. 2000, 47, 1067–1079. [Google Scholar] [PubMed]
  103. Humphrey, S.P.; Williamson, R.T. A review of saliva: Normal composition, flow, and function. J. Prosthet. Dent. 2001, 85, 162–169. [Google Scholar] [CrossRef] [PubMed]
  104. Berkovitz, B.K.B.; Holland, G.R.; Moxham, B.J. Oral Anatomy, Histology and Embryology, 3rd ed.; Mosby: New York, NY, USA, 2002. [Google Scholar]
  105. Ahmadi-Motamayel, F.; Falsafi, P.; Goodarzi, M.T.; Poorolajal, J. Evaluation of salivary catalase, vitamin C, and alpha-amylase in smokers and non-smokers: A retrospective cohort study. J. Oral Pathol. Med. 2016. [Google Scholar] [CrossRef] [PubMed]
  106. Holsinger, F.; Bui, D. Salivary Gland Disorders; Springer: Berlin, Germany, 2007. [Google Scholar]
  107. Grant, D.A.; Stern, I.B.; Listgarten, M.A. Periodontics, 6th ed.; CV Mosby: St. Louis, MO, USA, 1988; pp. 135–146. [Google Scholar]
  108. Forde, M.D.; Koka, S.; Eckert, S.E.; Carr, A.B.; Wong, D.T. Systemic assessments utilizing saliva: Part 1 general consideration and current assessments. Int. J. Prosthodont. 2006, 19, 43–52. [Google Scholar] [PubMed]
  109. Holmberg, K.V.; Hoffman, M.P. Anatomy, biogenesis and regeneration of salivary glands. Monogr. Oral Sci. 2014, 24, 1–13. [Google Scholar] [PubMed]
  110. De Almedia Pdel, V.; Gregio, A.M.; Machado, M.A.; de Lima, A.A.; Azevedo, L.R. Saliva Composition and Functions: A Comprehensive Review. J. Contemp. Dent. Pract. 2008, 9, 72–80. [Google Scholar]
  111. Pedersen, A.M.; Bardo, A.; Jensen, S.B.; Nauntofte, B. Saliva and gastrointestinal functions of taste, mastication, swallowing, and digestion. Oral Dis. 2002, 8, 117–129. [Google Scholar] [CrossRef] [PubMed]
  112. Mese, H.; Matsuo, R. Salivary secretion, taste and hyposalivation. J. Oral Rehabil. 2007, 34, 711–723. [Google Scholar] [CrossRef] [PubMed]
  113. Edgar, W. Saliva and dental health. Clinical implications of saliva: Report of a consensus meeting. Br. Dent. J. 1990, 169, 96–98. [Google Scholar] [CrossRef] [PubMed]
  114. Delaney, K.P.; Branson, B.M.; Uniyal, A.; Kerndt, P.R.; Keenan, P.A.; Jafa, K.; Gardner, A.D.; Jamieson, D.J.; Bulterys, M. Performance of an oral fluid rapid HIV-1/2 test: Experience from four CDC studies. AIDS 2006, 20, 1655–1660. [Google Scholar] [CrossRef] [PubMed]
  115. Amado, L.A.; Villar, L.M.; de Paula, V.S.; de Almeida, A.J.; Gaspar, A.M. Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies. Mem. Inst. Oswaldo Cruz 2006, 101, 149–155. [Google Scholar] [CrossRef] [PubMed]
  116. Mager, D.L.; Haffajee, A.D.; Devlin, P.M.; Norris, C.M.; Posner, M.R.; Goodson, J.M. The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J. Transl. Med. 2005, 3, 27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  117. Paju, S.; Pussinen, P.J.; Suominen-Taipale, L.; Hyvönen, M.; Knuuttila, M.; Könönen, E. Detection of multiple pathogenic species in saliva is associated with periodontal infection in adults. J. Clin. Microbiol. 2009, 47, 235–238. [Google Scholar] [CrossRef] [PubMed]
  118. Paster, B.J.; Dewhirst, F.E. Molecular microbial diagnosis. Periodontology 2000 2009, 51, 38–44. [Google Scholar] [CrossRef] [PubMed]
  119. Goodson, J.M.; Groppo, D.; Halem, S.; Carpino, E. Is obesity an oral bacterial disease? J. Dent. Res. 2009, 88, 519–523. [Google Scholar] [CrossRef] [PubMed]
  120. Wang, J.; Schipper, H.M.; Velly, A.M.; Mohit, S.; Gornitsky, M. Salivary biomarkers of oxidative stress: A critical review. Free Radic. Biol. Med. 2015, 85, 95–104. [Google Scholar] [CrossRef] [PubMed]
  121. Saral, Y.; Coskun, B.K.; Ozturk, P.; Karatas, F.; Ayar, A. Assessment of salivary and serum antioxidant vitamins and lipid peroxidation in patients with recurrent aphthous ulceration. Tohoku J. Exp. Med. 2005, 206, 305–312. [Google Scholar] [CrossRef] [PubMed]
  122. Khademi, H.; Khozeimeh, F.; Tavangar, A.; Amini, S.; Parichehr, G. The serum and salivary level of malondialdehyde, vitamins A, E, and C in patient with recurrent aphthous stomatitis. Adv. Biomed. Res. 2014, 3, 246. [Google Scholar] [PubMed]
  123. Al-Rawi, N.H. Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diabetes Vasc. Dis. Res. 2011, 8, 22–28. [Google Scholar] [CrossRef] [PubMed]
  124. Major, R.H. A History of Medicine; Blackwell: Springfield, IL, USA, 1954; p. 51. [Google Scholar]
  125. Stuteville, O.H. Presence of Vitamin C in Saliva. Proc. Soc. Exp. Biol. 1935, 32, 1454–1455. [Google Scholar] [CrossRef]
  126. Mäkilä, E.; Kirveskari, P. A study of ascorbic acid in human saliva. Arch. Oral Biol. 1969, 14, 1285–1292. [Google Scholar] [CrossRef]
  127. Dessy, J.; Doneddu, K. Einfluss des insulins auf die vitamin C- Ausscheidung im Harn und Speichel nach intravenöser Ascorbinsäure-Belastung bei Normalen und Diabetkern. Endokrinologie 1940, 23, 165–175. [Google Scholar]
  128. Dreizen, S.; Gilley, E.J.; Mosny, J.J.; Spies, T.D. The distribution of selected vitamins in human whole saliva. Int. Z. Vitaminforsch. Beih. 1955, 26, 257–262. [Google Scholar] [PubMed]
  129. Freeman, J.T.; Hafkesbring, R. Comparative study of ascorbic acid levels in gastric secretion, blood, urine and saliva. Gastroenterology 1951, 18, 224–229. [Google Scholar] [PubMed]
  130. Glavind, J.; Grandados, H.; Hansen, L.A.; Schilling, K.; Kruse, I.; Dam, H. The presence of vitamins in the saliva. Int. Z. Vitam. Forsch. 1948, 20, 234–238. [Google Scholar]
  131. Hess, W.C.; Smith, B.T. The ascorbic acid content of the saliva of carious and noncarious individuals. J. Dent. Res. 1949, 28, 507–511. [Google Scholar] [CrossRef] [PubMed]
  132. Zimmet, D.; Dubois-Ferrière, H. Vitamine C dans la salive humaine et paradentoses. C. R. Sèanc. Soc. Phys. Hist. Nat. Genève 1936, 53, 151–154. [Google Scholar]
  133. Leggott, P.J.; Robertson, P.B.; Rothman, D.L.; Murrary, P.A.; Jacob, R.A. Response of lingual ascorbic acid test and salivary ascorbate levels to changes in ascorbic acid intake. J. Dent. Res. 1986, 65, 131–134. [Google Scholar] [CrossRef] [PubMed]
  134. Levine, M.; Conry-Cantilena, C.; Wang, Y.; Welch, R.W.; Washko, P.W.; Dhariwal, K.R.; Park, J.B.; Lazarev, A.; Graumlich, J.F.; King, J.; et al. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc. Natl. Acad. Sci. USA 1996, 93, 3704–3709. [Google Scholar] [CrossRef] [PubMed]
  135. Bijos, G.M. Determination of ascorbic acid in the saliva of tuberculous subjects. Chem. Abstr. 1948, 42, 5548. [Google Scholar]
  136. Abdolsamadi, H.; Rafieian, N.; Goodarzi, M.T.; Feradmal, J.; Davoodi, P.; Jazayeri, M.; Taghavi, Z.; Hoseyni, S.M.; Ahmadi-Motamayel, F. Levels of salivary antioxidant vitamins and lipid peroxidation in patients with oral lichen planus and healthy individuals. Chonnam Med. J. 2014, 50, 58–62. [Google Scholar] [CrossRef] [PubMed]
  137. Kaur, J.; Politis, C.; Jacobs, R. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: Diagnostic value and free radical mechanism of action. Clin. Oral Investig. 2016, 20, 315–319. [Google Scholar] [CrossRef] [PubMed]
  138. Patni, V.; Baliga, S.; Sawal, S. Saliva as a diagnostic tool for measurement of total antioxidant capacity in children with leprosy and born to leprosy parent. Indian J. Lepr. 2015, 87, 17–21. [Google Scholar] [PubMed]
  139. Shetty, S.R.; Babu, S.; Kumari, S.; Shetty, P.; Vijay, R.; Karikal, A. Evaluation of micronutrient status in serum and saliva of oral submucous fibrosis patients: A clinicopathological study. Indian J. Med. Paediatr. Oncol. 2012, 33, 224–226. [Google Scholar] [CrossRef] [PubMed]
  140. Omaye, S.T.; Turnbull, J.D.; Sauberlich, H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol. 1979, 62, 3–11. [Google Scholar] [PubMed]
  141. Food and Nutrition Board. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids; National Academy Press: Washington, DC, USA, 2000; pp. 95–185. [Google Scholar]
  142. Levine, M.; Wang, Y.; Padayatty, S.; Morrow, J. A new recommended dietary allowance of Vitamin C for healthy young women. Proc. Natl. Acad. Sci. USA 2001, 98, 9842–9846. [Google Scholar] [CrossRef] [PubMed]
  143. Jacob, R.A.; Sotoudeh, G. Vitamin C function and status in chronic disease. Nutr. Clin. Care 2002, 5, 66–74. [Google Scholar] [CrossRef]
  144. Food Surveys Research Group. What We Eat in America, NHANES 2007–2010; US Department of Agriculture, Beltsville Human Nutrition Research Center: Beltsville, MD, USA, 2013.
  145. Padayatty, S.; Sun, H.; Wang, Y.; Riordan, H.D.; Hewitt, S.M.; Katz, A.; Wesley, R.A.; Levine, M. Vitamin C pharmacokinetics: Implications for oral and intravenous use. Ann. Intern. Med. 2004, 140, 533–537. [Google Scholar] [CrossRef] [PubMed]
  146. Combs, G.F., Jr. The Vitamins: Fundamental Aspects in Nutrition and Health, 3rd ed.; Elsevier Academic Press: Burlington, VT, USA, 2008. [Google Scholar]
  147. Kittisakmontri, K.; Swangtrakul, N.; Padungmaneesub, W.; Charoenkwan, P. Gingival bleeding and bloody dialysate: A case report of scurvy in a child with end-stage renal disease receiving peritoneal dialysis. J. Ren. Nutr. 2016, 26, 407–411. [Google Scholar] [CrossRef] [PubMed]
  148. Shaath, T.; Fischer, R.; Goeser, M.; Rajpara, A.; Aires, D. Scurvy in the present times: Vitamin C allergy leading to strict fast food diet. Dermatol. Online 2016, 22, 10. [Google Scholar]
  149. Vitoria, I.; Lόpez, B.; Gόmez, J.; Torres, C.; Calvo, I.; Dalmau, J. Improper use of a plant-based vitamin C-deficient beverage causes scurvy in an infant. Pediatrics 2016, 137, e20152781. [Google Scholar] [CrossRef] [PubMed]
  150. Kallner, A.B.; Hartmann, D.; Hornig, D.H. On the requirements of ascorbic acid in man: Steady-state turnover and body pool in smokers. Am. J. Clin. Nutr. 1981, 34, 1347–1355. [Google Scholar] [PubMed]
  151. Lykkesfeldt, J.; Christen, S.; Wallock, L.M.; Chang, H.H.; Jacob, R.A.; Ames, B.N. Ascorbate is depleted by smoking and repleted by moderate supplementation: A study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am. J. Clin. Nutr. 2000, 71, 530–536. [Google Scholar] [PubMed]
  152. Schectman, G.; Byrd, J.C.; Hoffman, R. Ascorbic acid requirements for smokers: Analysis of a population survey. Am. J. Clin. Nutr. 1991, 53, 1466–1470. [Google Scholar] [PubMed]
  153. Schectman, G.; Byrd, J.C.; Gruchow, H.W. The influence of smoking on vitamin C status in adults. Am. J. Public Health 1989, 79, 158–162. [Google Scholar] [CrossRef] [PubMed]
  154. Dorchy, H. Lower plasma vitamin C levels in young type 1 diabetic patients with microalbuminuria. J. Diabetes Complicat. 1999, 13, 119. [Google Scholar] [PubMed]
  155. Kaviarasan, K.; Arjunan, M.M.; Pugalendi, K.V. Lipid profile, oxidant-antioxidant status and glycoprotein components in hyperlipidemic patients with/without diabetes. Clin. Chim. Acta 2005, 362, 49–56. [Google Scholar] [CrossRef] [PubMed]
  156. Pekkala, M.; Hieta, R.; Kursula, P.; Kivirikko, K.I.; Wierenga, R.K.; Myllyharju, J. Crystallization of the proline-rich-pepride binding domain of hyman type 1 collagen prolyl 4-hydroxylase. Acta. Crystallogr. D Biol. Crystallogr. 2003, 59, 940–942. [Google Scholar] [CrossRef] [PubMed]
  157. Peterkofsky, B. Ascorbate requirement for hydroxylation and secretion of procollagen: Relationship to inhibition of collagen synthesis in scurvy. Am. J. Clin. Nutr. 1991, 54, S1135–S1140. [Google Scholar]
  158. Prockop, D.J.; Kivirikko, K.I. Collagens: Molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 1995, 64, 403–434. [Google Scholar] [CrossRef] [PubMed]
  159. Rebouche, C.J. Ascorbic acid and carnitine biosynthesis. Am. J. Clin. Nutr. 1991, 54, S1147–S1152. [Google Scholar]
  160. Levine, M.; Dhariwal, K.R.; Washko, P.W.; Butler, J.D.; Welch, R.W.; Wang, Y.H.; Bergsten, P. Ascorbic acid and in situ kinetics: A new approach to vitamin requirements. Am. J. Clin. Nutr. 1991, 54, S1157–S1162. [Google Scholar] [CrossRef]
  161. Lindblad, B.; Lindstedt, G.; Lindstedt, S. The mechanism of enzymic formation of homogentisate from p-hydroxyphenylpyruvate. J. Am. Chem. Soc. 1970, 92, 7446–7449. [Google Scholar] [CrossRef] [PubMed]
  162. Sieburg, H. Redoxon as a tonic for sportsmen. Dtsch. Med. Wochenschr. 1937, 63, 11–12. [Google Scholar]
  163. Jetzler, A.; Haffler, C. Vitamin C- Bedarf bei einmaligar sportlicher Dauerleistung. Wein. Med. Wochenschr. 1939, 89, 332. [Google Scholar]
  164. Sauberlich, H.E. Pharmacology of vitamin-C. Ann. Rev. Nutr. 1994, 14, 371–391. [Google Scholar] [CrossRef] [PubMed]
  165. Chow, C.K.; Thacker, R.R.; Changchit, C.; Bridges, R.B.; Rehm, S.R.; Humble, J.; Turbek, J. Lower levels of vitamin C and carotenes in plasma of cigarette smokers. J. Am. Coll. Nutr. 1986, 5, 305–312. [Google Scholar] [CrossRef] [PubMed]
  166. Namyslowski, L.; Desperak-Secomska, B. The vitamin C content of the blood in a selected group of students during 1952 and 1953. Rocz. Panstw. Zakl. Hig. 1955, 6, 289. [Google Scholar]
  167. Namyslowski, L. Investigations of the vitamin C requirements of athletes during physical exertion. Rocz. Panstw. Zakl. Hig. 1956, 7, 97–122. [Google Scholar]
  168. Ferrandez, M.D.; Maynar, M.; De la Fuente, M. Effects of a long-term training program of increasing intensity on the immune function of indoor Olympic cyclists. Int. J. Sports Med. 1996, 17, 592–596. [Google Scholar] [CrossRef] [PubMed]
  169. Gleeson, M.; Robertson, J.D.; Maughan, R.J. Influence of exercise on ascorbic acid status in man. Clin. Sci. 1987, 73, 501–505. [Google Scholar] [CrossRef] [PubMed]
  170. Maxwell, S.R.; Jakeman, P.; Thomason, H.; Leguen, C.; Thorpe, G.H. Changes in plasma antioxidant status during eccentric exercise and the effect of vitamin supplementation. Free Radic. Res. Commun. 1993, 19, 191–202. [Google Scholar] [CrossRef] [PubMed]
  171. Petersen, E.W.; Ostrowski, K.; Ibfelt, T.; Richelle, M.; Offord, E.; Halkjaer-Kristensen, J.; Pedersen, B.K. Effect of vitamin supplementation on cytokine response and on muscle damage after strenuous exercise. Am. J. Physiol. Cell Physiol. 2001, 280, C1570–C1575. [Google Scholar] [PubMed]
  172. Peake, J.M. Vitamin C: Effects of exercise and requirements with training. Int. J. Sport Nutr. Exerc. Metab. 2003, 13, 125–151. [Google Scholar] [CrossRef] [PubMed]
  173. Vasankari, T.; Kujala, U.; Sarna, S.; Ahotupa, M. Effects of ascorbic acid and carbohydrate ingestion on exercise induced oxidative stress. J. Sports Med. Phys. Fit. 1998, 38, 281–285. [Google Scholar]
  174. Ashton, T.; Young, I.S.; Peters, J.R.; Jones, E.; Jackson, S.K.; Davies, B.; Rowlands, C.C. Electron spine resonance spectroscopy, exercise, and oxidative stress: An ascorbic acid intervention study. J. Appl. Physiol. 1999, 87, 2032–2036. [Google Scholar] [PubMed]
  175. Popovic, L.M.; Mitic, N.R.; Miric, D.; Bisevac, B.; Miric, M.; Popovic, B. Influence of vitamin C supplementation on oxidative stress and neutrophil inflammatory response in acute and regular exercise. Oxidative Med. Cell. Longev. 2015. [Google Scholar] [CrossRef] [PubMed]
  176. Cobley, J.N.; McHardy, H.; Morton, J.P.; Nikolaidis, M.G.; Close, G.L. Influence of vitamin C and vitamin E on redox signaling: Implications for exercise adaptations. Free Radic. Biol. Med. 2015, 84, 65–76. [Google Scholar] [CrossRef] [PubMed]
  177. Paulsen, G.; Cumming, K.T.; Holden, G.; Hallén, J.; Rønnestad, B.R.; Sveen, O.; Skaug, A.; Paur, I.; Bastani, N.E.; Østgaard, H.N.; et al. Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: A double-blind, randomized, controlled trial. J. Physiol. 2014, 592, 1887–1901. [Google Scholar] [CrossRef] [PubMed]
  178. Morrison, D.; Hughes, J.; Della Gatta, P.A.; Mason, S.; Lamon, S.; Russell, A.P.; Wadley, G.D. Vitamin C and E supplementation prevents some of the cellular adaptation to endurance-training in humans. Free Radic. Biol. Med. 2015, 89, 852–862. [Google Scholar] [CrossRef] [PubMed]
  179. Ristow, M.; Zarse, K.; Oberbach, A.; Klöting, N.; Birringer, M.; Kiehntopf, M.; Stumvoll, M.; Kahn, C.R.; Blüher, M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. USA 2009, 106, 8665–8670. [Google Scholar] [CrossRef] [PubMed]
  180. Gomez-Cabrera, M.C.; Domenech, E.; Romagnoli, M.; Arduini, A.; Borras, C.; Pallardo, F.V.; Sastre, J.; Viña, J. Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am. J. Clin. Nutr. 2008, 87, 142–149. [Google Scholar] [PubMed]
  181. Meyer, B.J.; deBruin, E.J.; Brown, J.M.; Bieler, E.U.; Meyer, A.C.; Grey, P.C. The effect of a predominately fruit diet on athletic performance. Plant Foods Man 1975, 1, 223. [Google Scholar]
  182. Thompson, D.; Williams, C.; Kingsley, M.; Nicholas, C.W.; Lakomy, H.K.; McArdle, F.; Jackson, M.J. Muscle soreness and damage parameters after prolonged intermittent shuttle-running following acute vitamin C supplementation. Int. J. Sports Med. 2001, 22, 68–75. [Google Scholar] [CrossRef] [PubMed]
  183. Nieman, D.C.; Henson, D.A.; McAnulty, S.R.; McAnulty, L.; Swick, N.S.; Utter, A.C.; Vinci, D.M.; Opiela, S.J.; Morrow, J.D. Influence of vitamin C supplementation on oxidative and immune changes after an ultramarathon. J. Appl. Physiol. 2002, 92, 1970–1977. [Google Scholar] [CrossRef] [PubMed]
  184. Howald, H.; Segesser, B.; Körner, W.F. Ascorbic acid and athletic performance. Ann. N. Y. Acad. Sci. 1975, 258, 458–464. [Google Scholar] [CrossRef] [PubMed]
  185. Samata, S.C.; Biswas, K. Effect of supplementation of vitamin C on the cardiorespiratory endurance capacity of college women. Snipes J. 1985, 8, 55. [Google Scholar]
  186. Thompson, D.; Williams, C.; McGregor, S.J.; Nicholas, C.W.; McArdle, F.; Jackson, M.J.; Powell, J.R. Prolonged vitamin C supplementation and recovery from demanding exercise. Int. J. Sports Nutr. Exerc. Metab. 2001, 11, 466–481. [Google Scholar] [CrossRef]
  187. Roberts, L.A.; Beattie, K.; Close, G.L.; Morton, J.P. Vitamin C consumption does not impair training-induced improvements in exercise performance. Int. J. Sports Physiol. Perform. 2011, 6, 58–69. [Google Scholar] [CrossRef] [PubMed]
  188. Gey, G.O.; Cooper, K.H.; Bottenberg, R.A. Effect of ascorbic acid on endurance performance and athletic injury. JAMA 1970, 211, 105. [Google Scholar] [CrossRef] [PubMed]
  189. Wacholder, K. Rise in the turnover and destruction of ascorbic acid (vitamin C) during muscle work. Arbeisphysiologie 1951, 14, 342. [Google Scholar]
  190. Lemmel, G. Vitamin C deficiency and general capacity for work. Munchener Medizinische Wochenschrift 1938, 85, 1381. [Google Scholar]
  191. Buzina, R.; Suboticanec, K. Vitamin C and physical working capacity. Int. J. Vitam. Nutr. Res. Suppl. 1985, 27, 157–166. [Google Scholar] [PubMed]
  192. Paschalis, V.; Theodorou, A.A.; Kyparos, A.; Dipla, K.; Zafeiridis, A.; Panayiotou, G.; Vrabas, I.S.; Nikolaidis, M.G. Low vitamin C values are linked with decreased physical performance and increased oxidative stress: Reversal by vitamin C supplementation. Eur. J. Nutr. 2016, 55, 45–53. [Google Scholar] [CrossRef] [PubMed]
  193. Gerster, H. The role of vitamin C in athletic performance. J. Am. Coll. Nutr. 1989, 8, 636–643. [Google Scholar] [CrossRef] [PubMed]
  194. Carpenter, K.J. The History of Scurvy & Vitamin C; Cambridge Unniversity Press: London, UK, 1986. [Google Scholar]
  195. Bates, J.F.; Hughes, R.E.; Hurley, R.J. Ascorbic acid status in man: Measurement of salivary, plasma, and white blood cell concentration. Arch. Oral Biol. 1972, 17, 1017–1020. [Google Scholar] [CrossRef]
  196. Paulsen, G.; Hamarsland, H.; Cumming, K.T.; Johansen, R.E.; Hulmi, J.J.; Børsheim, E.; Wiig, H.; Garthe, I.; Raastad, T. Vitamin C and E supplementation alters protein signaling after a strength training session, but not muscle growth during 10 weeks of training. J. Physiol. 2014, 592, 5391–5408. [Google Scholar] [CrossRef] [PubMed]
  197. Bobeuf, F.; Labonte, M.; Dionne, I.J.; Khalil, A. Combined effect of antioxidant supplementation and resistance training on oxidative stress markers, muscle and body composition in an elderly population. J. Nutr. Health Aging 2011, 15, 883–889. [Google Scholar] [CrossRef] [PubMed]
  198. Wolff, C.; Musci, R.; Whedbee, M. Vitamin supplementation and resistance exercise-induced muscle hypertrophy: Shifting the redox balance scale? J. Physiol. 2015, 593, 2991–2992. [Google Scholar] [CrossRef] [PubMed]
  199. Bryer, S.C.; Goldfarb, A.H. Effect of high dose vitamin C supplementation on muscle soreness, damage, function, and oxidative stress to eccentric exercise. Int. J. Sport Nutr. Exerc. Metab. 2006, 16, 270–280. [Google Scholar] [CrossRef] [PubMed]
  200. Powers, S.K.; Jackson, M.J. Exercise-induced oxidative stress: Cellular mechanisms and impact on muscle force production. Physiol. Rev. 2008, 88, 1243–1276. [Google Scholar] [CrossRef] [PubMed]
  201. Lamb, G.D.; Westerblad, H. Acute effects of reactive oxygen and nitrogen species on the contractile function of skeletal muscle. J. Physiol. 2011, 589, 2119–2127. [Google Scholar] [CrossRef] [PubMed]
  202. Andrade, F.H.; Redi, M.B.; Allen, D.G.; Westerblad, H. Effect of hydrogen peroxide and dithothreitol on contractile function of single skeletal muscle fibres from the mouse. J. Physiol. 1998, 509, 565–575. [Google Scholar] [CrossRef] [PubMed]
  203. Steinbacher, P.; Eckl, P. Impact of oxidative stress on exercising skeletal muscle. Biomolecules 2015, 5, 356–377. [Google Scholar] [CrossRef] [PubMed]
Figure 1. An example of a non-free radical (all electrons within orbital are paired) and a free radical (at least one electron within orbital is unpaired). The superoxide radical has an unpaired electron within its orbital; the unpaired electron creates a reactive compound capable of producing oxidative damage [2,3].
Figure 1. An example of a non-free radical (all electrons within orbital are paired) and a free radical (at least one electron within orbital is unpaired). The superoxide radical has an unpaired electron within its orbital; the unpaired electron creates a reactive compound capable of producing oxidative damage [2,3].
Antioxidants 06 00005 g001
Figure 2. Skeletal muscle during (A) and after (B) exercise. (A) during exercise, as intensity reaches the point of VO2max (maximum volume of oxygen uptake) muscular oxygen is depleted; (B) after exercise, muscular oxygen is repleted at such a fast pace potentially-damaging free radicals are produced [71,72].
Figure 2. Skeletal muscle during (A) and after (B) exercise. (A) during exercise, as intensity reaches the point of VO2max (maximum volume of oxygen uptake) muscular oxygen is depleted; (B) after exercise, muscular oxygen is repleted at such a fast pace potentially-damaging free radicals are produced [71,72].
Antioxidants 06 00005 g002
Figure 3. Balance between antioxidants and oxidants in untrained and trained individuals in as it relates to exercise benefits. An individual who is less experienced in exercise might find more of a benefit with higher concentrations of systemic antioxidants (such as via supplementation); an individual who is more trained in exercise might find more of a benefit with higher concentrations of systemic oxidants (free radicals/reactive species with their respective roles in exercise adaptation [203].
Figure 3. Balance between antioxidants and oxidants in untrained and trained individuals in as it relates to exercise benefits. An individual who is less experienced in exercise might find more of a benefit with higher concentrations of systemic antioxidants (such as via supplementation); an individual who is more trained in exercise might find more of a benefit with higher concentrations of systemic oxidants (free radicals/reactive species with their respective roles in exercise adaptation [203].
Antioxidants 06 00005 g003

Share and Cite

MDPI and ACS Style

Evans, L.W.; Omaye, S.T. Use of Saliva Biomarkers to Monitor Efficacy of Vitamin C in Exercise-Induced Oxidative Stress. Antioxidants 2017, 6, 5. https://doi.org/10.3390/antiox6010005

AMA Style

Evans LW, Omaye ST. Use of Saliva Biomarkers to Monitor Efficacy of Vitamin C in Exercise-Induced Oxidative Stress. Antioxidants. 2017; 6(1):5. https://doi.org/10.3390/antiox6010005

Chicago/Turabian Style

Evans, Levi W., and Stanley T. Omaye. 2017. "Use of Saliva Biomarkers to Monitor Efficacy of Vitamin C in Exercise-Induced Oxidative Stress" Antioxidants 6, no. 1: 5. https://doi.org/10.3390/antiox6010005

APA Style

Evans, L. W., & Omaye, S. T. (2017). Use of Saliva Biomarkers to Monitor Efficacy of Vitamin C in Exercise-Induced Oxidative Stress. Antioxidants, 6(1), 5. https://doi.org/10.3390/antiox6010005

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop